TA-MUC1 expression was identified across a wide range of tumor types, most frequently in gastrointestinal, breast, and gynecologic cancers, but also in less common malignancies such as sarcomatoid carcinoma and pleural mesothelioma. Here, MUC1 is linked to sarcomatoid carcinoma.